Raymond James analyst Laura Prendergast downgraded Mural Oncology (MURA) to Outperform from Strong Buy with an $18 price target
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off